Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters











Publication year range
1.
Water Sci Technol ; 61(9): 2317-24, 2010.
Article in English | MEDLINE | ID: mdl-20418629

ABSTRACT

Wastewater generated in industrial production processes are often contaminated by hazardous chemicals. Characterization by means of toxicity-directed analysis is useful for identifying which fractions of a waste stream possess the most toxicity. We applied this approach to evaluate toxic components of a polyester manufacturing wastewater. Using the reduction in oxygen uptake rate of activated sludge as an indicator of toxicity, it was determined that increasing the pH from 3 to 11 followed by air stripping significantly reduced the toxicity of the wastewater. Comparative headspace GC/MS analysis of wastewater at different pHs selected a group of Volatile Organic Compounds (VOCs) associated with the observed effect of air stripping at pH 11. Ten of these compounds were identified as alpha,beta unsaturated aldehydes (acrolein (2-propenal) congeners); these compounds are known to be toxic as well as mutagenic. Confirmation that these compounds were a cause of toxicity was achieved by demonstrating that removal of these compounds by air stripping significantly reduced the wastewater mutagenic potency in a Salmonella mutagenicity assay. Formation of these volatile compounds by base catalyzed aldol condensation at pH 11 may account for the effectiveness of air stripping in reducing toxicity. To date there is no record in the literature about the toxicity and presence of acrolein congeners in polyester manufacturing wastewater.


Subject(s)
Aldehydes/toxicity , Biomass , Polyesters/chemistry , Sewage , Waste Disposal, Fluid/methods , Aldehydes/chemistry , Bacteria/drug effects , Bioreactors , Hydrogen-Ion Concentration , Industrial Waste , Textile Industry , Water Pollutants, Chemical/chemistry , Water Pollutants, Chemical/toxicity
2.
Ann Surg ; 223(2): 116-26, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8597504

ABSTRACT

OBJECTIVE: The purpose of this report was to provide detailed information on the safety and feasibility of surgical procedures associated with the first ex vivo liver-directed gene therapy trial for the treatment of vivo gene therapy for homozygous familial hypercholesterolemia (FH). SUMMARY BACKGROUND DATA: Familial hypercholesterolemia is an autosomal dominant disease in which the gene encoding the low density lipoprotein receptor is defective. Patients homozygous for this mutation have extraordinarily high levels of cholesterol and accelerated atherosclerosis and die prematurely of myocardial infarction. The concept of liver-directed gene therapy was based on the report of normalization of cholesterol levels by orthotopic cardiac/liver transplant in a child with homozygous FH. METHODS: Five patients with homozygous FH were selected for inclusion in this trial. The patients underwent hepatic resection and placement of a portal venous catheter. Primary hepatocytes cultures were prepared from the resected liver and transduced with a recombinant retrovirus encoding the gene for the human low density lipoprotein receptor. The genetically modified cells were then transplanted into the liver through the portal venous catheter. RESULTS: Numerous clinical, laboratory, and radiologic parameters were analyzed. Elevations of the hepatic transaminases and leukocyte counts and a decline in hematocrit count were noted. Transient elevations of the portal pressure were observed during cell infusion. No major perioperative morbidity--specifically, myocardial infarct, perioperative hemorrhage, or portal vein thrombosis--or death occurred as a result of this protocol. CONCLUSION: Liver-directed ex vivo gene therapy can be accomplished safely in humans and is appropriate for selected patients.


Subject(s)
Genetic Therapy/methods , Homozygote , Hyperlipoproteinemia Type II/genetics , Adult , Canada/ethnology , Child , China/ethnology , Colombia/ethnology , Combined Modality Therapy , Cyprus/ethnology , Feasibility Studies , Female , Hepatectomy , Humans , Hyperlipoproteinemia Type II/ethnology , Hyperlipoproteinemia Type II/therapy , Liver , Male
5.
J Pediatr ; 100(5): 715-21, 1982 May.
Article in English | MEDLINE | ID: mdl-7069532

ABSTRACT

Six infants with disseminated HSV had no mucocutaneous lesions at any time during the course of the illness. These infants presented with lethargy, poor feeding, apnea, acidosis, and hepatomegaly. The diagnosis of HSV was made by culturing the infant's oropharynx and blood, and the maternal cervix. Eight infants with HSV encephalitis had no skin, eye, or mucous membrane lesions. These infants presented with lethargy and low-grade fever, followed within 24 hours by the onset of focal partial motor seizures. The seizures were refractory to anticonvulsant therapy. The mean CSF white cell count was 131 cells/mm3;the glucose and protein concentrations were in the normal range. Brain biopsy was required for the early diagnosis of HSV encephalitis. These 14 cases presented 70% (14/20) of all infants with neonatal HSV diagnosed during the study period. HSV infection should be considered in infants with no mucocutaneous lesions who have signs usually associated with bacterial sepsis or who develop focal seizures during the first three weeks of life.


Subject(s)
Herpes Simplex/congenital , Mucous Membrane/pathology , Skin/pathology , Encephalitis/cerebrospinal fluid , Encephalitis/congenital , Encephalitis/diagnosis , Herpes Simplex/cerebrospinal fluid , Herpes Simplex/pathology , Humans , Infant, Newborn
8.
J Pediatr ; 95(3): 444-6, 1979 Sep.
Article in English | MEDLINE | ID: mdl-224161

ABSTRACT

Over a four-month period, urine specimens for viral isolation were obtained weekly from all infants older than three weeks in two intensive care nurseries. These babies comprised 43% of the patients in the nurseries surveyed. Cytomegalovirus was cultured from 13 of 93 (14%) of these infants. Eleven of 13 infants who developed cytomegaloviruria were born prematurely, and nine of these 11 were found to be excreting CMV before they reached 40 weeks postconception. Infants excreting CMV received blood transfusions from a mean of 10.45 (+/- 1.80 SE) different donors versus 5.10 (+/- 0.55 SE) for infants without viruria (P less than 0.002) and five of 14 infants undergoing one or more exchange transfusions developed cytomegaloviruria (P less than 0.05). The possible role of other CMV reservoirs and the importance of these findings are discussed.


Subject(s)
Cytomegalovirus Infections/epidemiology , Infant, Newborn, Diseases/epidemiology , Intensive Care Units , Nurseries, Hospital , Cross Infection/transmission , Cytomegalovirus/isolation & purification , Cytomegalovirus Infections/transmission , Exchange Transfusion, Whole Blood/adverse effects , Humans , Infant, Newborn , Infant, Newborn, Diseases/transmission , Transfusion Reaction
11.
J Pediatr ; 89(2): 182-5, 1976 Aug.
Article in English | MEDLINE | ID: mdl-781195

ABSTRACT

It is clear that the group B streptococcus has become a major pathogen of young infants within the comparatively recent past. Further it is clear that, as with other endemic and epidemic pathogens, increasing clinical and laboratory experience brings to light variations not initially evident. In addition, therapy presumably effective in initial cases may not continue to be so. The following papers by coincidence were received over a relatively brief period of time. Hence, for emphasis of some of the problems related to this organism, they are presented as a group.


Subject(s)
Streptococcal Infections/drug therapy , Streptococcus agalactiae/pathogenicity , Ampicillin/therapeutic use , Cerebrospinal Fluid/microbiology , Drug Therapy, Combination , Humans , Infant, Newborn , Infant, Newborn, Diseases/drug therapy , Kanamycin/therapeutic use , Male , Microbial Sensitivity Tests , Penicillin G/therapeutic use , Pneumonia/drug therapy , Recurrence , Sepsis/drug therapy , Streptococcus agalactiae/drug effects
12.
Buenos Aires; El Ateneo; 1954. xii, 1004 p. il..
Monography in Spanish | LILACS-Express | BINACIS | ID: biblio-1214402
13.
Buenos Aires; El Ateneo; 1954. xii, 1004 p. il.. (110446).
Monography in Spanish | BINACIS | ID: bin-110446
14.
Buenos Aires; El Ateneo; 1954. xii, 1004 p. il.. (110445).
Monography in Spanish | BINACIS | ID: bin-110445
SELECTION OF CITATIONS
SEARCH DETAIL